Detalhes do Documento

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as The...

Autor(es): Cardoso, Susana cv logo 1 ; Santos, Renato cv logo 2 ; Correia, Sonia cv logo 3 ; Carvalho, Cristina cv logo 4 ; Zhu, Xiongwei cv logo 5 ; Lee, Hyoung-Gon cv logo 6 ; Casadesu, Gemma cv logo 7 ; Smith, Mark A. cv logo 8 ; Perry, George cv logo 9 ; Moreira, Paula I. cv logo 10

Data: 2009

Identificador Persistente: http://hdl.handle.net/10316/13013

Origem: Estudo Geral - Universidade de Coimbra

Assunto(s): Alzheimer’s disease; Amyotrophic lateral sclerosis; Huntington’s disease; Insulin; Mitochondria; Neurodegeneration; Parkinson’s disease; PPARs agonists


Descrição
Insulin, besides its glucose lowering effects, is involved in the modulation of lifespan, aging and memory and learning processes. As the population ages, neurodegenerative disorders become epidemic and a connection between insulin signaling dysregulation, cognitive decline and dementia has been established. Mitochondria are intracellular organelles that despite playing a critical role in cellular metabolism are also one of the major sources of reactive oxygen species. Mitochondrial dysfunction, oxidative stress and neuroinflammation, hallmarks of neurodegeneration, can result from impaired insulin signaling. Insulin-sensitizing drugs such as the thiazolidinediones are a new class of synthetic compounds that potentiate insulin action in the target tissues and act as specific agonists of the peroxisome proliferator-activated receptor gamma (PPAR-γ). Recently, several PPAR agonists have been proposed as novel and possible therapeutic agents for neurodegenerative disorders. Indeed, the literature shows that these agents are able to protect against mitochondrial dysfunction, oxidative damage, inflammation and apoptosis. This review discusses the role of mitochondria and insulin signaling in normal brain function and in neurodegeneration. Furthermore, the potential protective role of insulin and insulin sensitizers in Alzheimer´s, Parkinson´s and Huntington´s diseases and amyotrophic lateral sclerosis will be also discussed
Tipo de Documento Recensão
Idioma Inglês
delicious logo  facebook logo  linkedin logo  twitter logo 
degois logo
mendeley logo

Documentos Relacionados



    Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência Programa Operacional da Sociedade do Conhecimento União Europeia